CASE STUDY: IRELANDFBASED DRUG MAKER ACTAVIS BUYS U.S. PHARMACEUTICALS FIRM
Question # 00546800
Posted By:
Updated on: 06/15/2017 05:12 AM Due on: 06/15/2017
END OF CHAPTER CASE STUDY: IRELANDFBASED DRUG
MAKER ACTAVIS BUYS U.S. PHARMACEUTICALS FIRM
FOREST LABS Case Study Objectives: To Illustrate - Alternative mntives for Whirl-def acquisitions
- Hnw taxes impact Wile-r deals and capital flaws - How activist irwestm‘s can impact mrpm-ate decisixms. Re?ecting the eacala?ng meats 0f develnping blmkbuster drugs (i.e., thee-3e with the potential
MAKER ACTAVIS BUYS U.S. PHARMACEUTICALS FIRM
FOREST LABS Case Study Objectives: To Illustrate - Alternative mntives for Whirl-def acquisitions
- Hnw taxes impact Wile-r deals and capital flaws - How activist irwestm‘s can impact mrpm-ate decisixms. Re?ecting the eacala?ng meats 0f develnping blmkbuster drugs (i.e., thee-3e with the potential
Discussion Questions ‘1. Using the common motives for a oss—border deals discuimed in this chapter pemlateas to
the reasons Actavis acquired Forest tabs.
the reasons Actavis acquired Forest tabs.
1 What alternatives to acquisition could Actavis have pursued? Spect?ate as to why a takeover
was the preferred option?
was the preferred option?
3. Speculate as to how Actavis's takeover of Forest labs may have created shareholder value?
4. Do you believe ?m'ns should be allowed to engage in tax inversions?
5. Why is Actavis mganized as a holding company in Ireland? ti. Speculate as to why invesmrs for both ?rms responded so favorably when news of the deal was announced? Solutions to these questions srefound in the Unline- Instructor's Ida-nun! available to instructors using this bulk.
-
Rating:
/5
Solution: CASE STUDY: IRELANDFBASED DRUG MAKER ACTAVIS BUYS U.S. PHARMACEUTICALS FIRM